Gene · 3131
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia. | NPJ Precis Oncol | 2023 | 38066241 | PubTator, text mining | PubMed |
| [Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049329 | PubTator, text mining | PubMed |
| A Prognostic Model of Genetic Markers for Triple-Negative Breast Cancer Based on Machine Learning and Bioinformatics Analysis. | Stud Health Technol Inform | 2023 | 38007754 | PubTator, text mining | PubMed |
| Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37981648 | PubTator, text mining | PubMed |
| PathExpSurv: pathway expansion for explainable survival analysis and disease gene discovery. | BMC Bioinformatics | 2023 | 37968615 | PubTator, text mining | PubMed |
| To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism. | Int J Mol Sci | 2023 | 37958908 | PubTator, text mining | PubMed |
| Lactoferrin, the Moonlighting Protein of Innate Immunity. | Int J Mol Sci | 2023 | 37958871 | PubTator, text mining | PubMed |
| AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens. | Int J Mol Sci | 2023 | 37958832 | PubTator, text mining | PubMed |
| Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli. | Protein Sci | 2023 | 37916438 | PubTator, text mining | PubMed |
| Inhibition of SARS-CoV-2 Infection in Vero Cells by Bovine Lactoferrin under Different Iron-Saturation States. | Pharmaceuticals (Basel) | 2023 | 37895823 | PubTator, text mining | PubMed |
| Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes. | Biomedicines | 2023 | 37892987 | PubTator, text mining | PubMed |
| Comprehensive analyses identify potential biomarkers for encephalitis in HIV infection. | Sci Rep | 2023 | 37891420 | PubTator, text mining | PubMed |
| Metabolic Basis of Circadian Dysfunction in Parkinson's Disease. | Biology (Basel) | 2023 | 37887004 | PubTator, text mining | PubMed |
| Low molecular weight chitosan oligosaccharides form stable complexes with human lactoferrin. | FEBS Open Bio | 2023 | 37872003 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies lactoferrin-induced quiescent circuits in neonatal macrophages. | Front Immunol | 2023 | 37868991 | PubTator, text mining | PubMed |
| Ethanol-exposed lung fibroblasts cause airway epithelial barrier dysfunction. | Alcohol Clin Exp Res (Hoboken) | 2023 | 37864530 | PubTator, text mining | PubMed |
| A new species of Passaloecus Shuckard (Hymenoptera, Crabronidae) from China, with a key to Oriental species. | Zookeys | 2023 | 37860602 | PubTator, text mining | PubMed |
| Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis. | J Transl Med | 2023 | 37853415 | PubTator, text mining | PubMed |
| The Study of Expression of Hypoxia-Inducible Factor-1 Alpha (HIF-1 Alpha) and Hypoxia-Inducible Factor-2 Alpha (HIF-2 Alpha) in Oral Squamous Cell Carcinoma: An Immunohistochemical Study. | Cureus | 2023 | 37842368 | PubTator, text mining | PubMed |
| An interactive resource of molecular signalling in the developing human haematopoietic stem cell niche. | Development | 2023 | 37840454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3131/papers?page=6